Navigation Links
Theranostics Health Signs Research Collaboration Agreement
Date:5/15/2008

ROCKVILLE, Md., May 15 /PRNewswire/ -- Theranostics Health (THX) today announced that it has entered into a three-year master research collaboration agreement with Duke University. This relationship will provide Duke investigators access to the company's core technologies: Laser Capture Microdissection (LCM) and Reverse Phase Protein Microarray (RPMA). The proprietary combination of these technologies provides a powerful mechanism to accurately and reliably measure the aberrant protein signaling and protein molecular networks used by tumor cells obtained directly from a patient's biopsy. This information can be used to investigate patient-specific treatments and individual treatment regimens, and also, to better understand the mechanisms of tumorigenesis in order to discover and develop new, safer and more effective therapies.

According to Dr. Neil Spector, Director of Duke's Translational Research Oncology Program, "those of us at Duke who are going to participate in this umbrella agreement with Theranostics Health are excited about the insight this collaboration may provide on the use of phosphoproteomics to shed light on the complexities of the signaling networks that regulate tumor cell growth, survival, migration/invasion, and resistance to targeted therapies. We are intrigued by the possibility of applying this information to investigate more effective therapies for our patients."

"The future of cancer treatment is personalized, targeted therapies and patient stratification for clinical trials," says Dr. Emanuel Petricoin, CSO of Theranostics Health. "We believe that this research collaboration with Duke, one of the top institutions in the world, will provide an important next step for our company in both research applications at the bench as well as working together with Duke investigators during phase I, II and III clinical trials."

Dr. Danong Chen, President and CEO of Theranostics Health, is equally optimistic about the master research agreement with Duke. "We are very pleased to begin collaboration with a nationally-recognized center of excellence and believe that Duke shares our vision of shaping a new paradigm in disease management. This relationship demonstrates the value of this technology for impacting healthcare delivery."

About Theranostics Health

Theranostics Health, LLC is a privately-held company founded in 2006 and based in Rockville, MD. Its core technology is the proprietary combination of Laser Capture Microdissection (LCM) and Reverse Phase Protein Microarray (RPMA) both developed by the company's co-founders Drs. Lance Liotta and Emanuel Petricoin III. The technology measures the activity of a large number of biomarkers, enabling pharmaceutical companies to accurately profile their drug candidates to more efficiently develop safer, more effective therapeutics. More importantly, it enables physicians to tailor optimized therapies to their patients based on the biomarker profile of each individual patient, providing safer and more effective therapies. Theranostics Health is currently working with 5 of the top 10 global pharmaceutical companies in their drug R&D efforts. For more information please email info@theranosticshealth.com or visit http://www.theranosticshealth.com.


'/>"/>
SOURCE Theranostics Health, LLC
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. NIH Grants Exclusive License to Theranostics Health
2. SXC Health Solutions to present at the FBR Capital Markets 12th Annual Spring Investor Conference
3. Mergent, Inc. Announces Changes to the HealthShares(TM) Composite Index, Dermatology and Wound Care Index and Orthopedic Repair Index - Correction
4. The 2008 AMIA Spring Congress to Showcase Best Practices and Innovations in Biomedical and Health Informatics Research and Education
5. Diagnostic Health Corporation Names Robert E. Gontarek as COO
6. Vancouver Coastal Health Authority Makes Waves With Patient Flow
7. Guardian Survey: Employees Are Confused About Their Health Coverage and Have No Plans for Healthcare in Retirement
8. Healthy Farms, Healthy Schools Grant Applications Available
9. Somanetics Corporation to Present at Citigroup 2008 Healthcare Conference
10. HealthSTAR Public Relations Hires Hayley Soffer, Executive Vice President
11. IADR and GlaxoSmithKline Consumer Healthcare announce winners
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... ... February 23, 2017 , ... Los Angeles-based weight loss surgeon Michael Feiz, ... June: From Not to Hot,” which will begin airing on February 24, 2017. The ... millions from the 2012 reality television series, “Here Comes Honey Boo Boo.” The earlier ...
(Date:2/23/2017)... ... February 23, 2017 , ... Rosica Communications, ... relations, content marketing, social media management, corporate communications, SEO and cause marketing, is ... and in nearby New Hampshire, Massachusetts and Canada, Rosica will focus on expanding ...
(Date:2/23/2017)... ... February 23, 2017 , ... On April ... diverse symposium on “Doping in Sport: How the Culture Might Change,” ... Hampton LLP. The symposium will be held at Pepperdine University in Malibu, California. ...
(Date:2/23/2017)... (PRWEB) , ... February 23, 2017 , ... ... an exciting, new, interactive publication where generations converge and explore the world from ... their worldview, Dialog Magazine enables readers to gain understanding, increase empathy, and find ...
(Date:2/23/2017)... ... , ... Current Meditation , a new meditation concept ... U.S. starting this spring. Current Meditation focuses on “meditation for the modern world,” ... will be the first meditation concept in the U.S. offering franchising opportunities, setting ...
Breaking Medicine News(10 mins):
(Date:2/24/2017)... Feb 24, 2017 Research and Markets has announced ... 2016" report to their offering. ... The latest research Hemophilia Drugs Price Analysis and Strategies - ... The research answers the following questions: ... How are they positioned in the Global Hemophilia market? ...
(Date:2/24/2017)... 24, 2017  In conjunction with DURECT Corporation,s (Nasdaq: ... press release, you are invited to listen to a ... internet on Tuesday, March 14, 2017 at 4:30 pm ... live audio webcast of the presentation will be available ... clicking "Investor Relations."  If you are unable to participate ...
(Date:2/24/2017)... Feb. 23, 2017 The U.S. Food ... PhenoTest BC Kit, performed on the Pheno System. ... that cause bloodstream infections and provide information about ... to (antibiotic sensitivity). The test also reduces the ... important information, which can guide antibiotic treatment recommendations ...
Breaking Medicine Technology: